Search for: "Astellas Pharma Inc."
Results 1 - 20
of 53
Sort by Relevance
|
Sort by Date
3 Nov 2023, 7:15 am
The present case started as a claim for infringement brought by Astellas Pharma Inc (“Astellas”) against Teva and Sandoz (the “Defendants”). [read post]
15 Aug 2023, 4:29 am
Jane LambertCourt of Appeal (Lords Justices Arnold and Stuart-Smith and Lady Justice Falk) Teva Pharmaceutical Industries Ltd and another v Astellas Pharma Inc [2023] EWCA Civ 880 (25 July 2023) This was an appeal against the dismissal of the claim by Teva Pharmaceutical Industries Ltd. and Teva UK Ltd. [read post]
14 May 2023, 7:07 pm
.'s Shanghai offices, the rad on the Beijing offices of Mintz Group, cyber reviews of Micron Technology, Inc., and the detention of a Japanese employee of Astellas Pharma, Inc., suggests a broader purpose.Business executives who have consulted with Chinese authorities said the government aims to limit the information collected by foreign companies such as auditors, management consultants, and law firms that could influence how the outside world views China. [read post]
6 Dec 2022, 4:50 pm
Astellas Pharma US, Inc., Circuit Court of Cook County, Illinois County Dept., Chancery Div., 2019 CH 14483 (Nov. 28, 2022). [read post]
4 Aug 2022, 7:54 pm
Pfizer, Inc. v. [read post]
22 Oct 2021, 2:10 pm
As stated in our initial article about serious Padcev skin reactions last month, we are investigating cases of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in patients using Padcev as possible drug injury lawsuits to be filed against Astellas Pharma US, Inc., the manufacturer of Padcev. [read post]
21 Sep 2021, 1:25 pm
Our law firm is investigating cases for patients who have suffered the Padcev skin side effects Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) as possible drug injury lawsuits to be filed against Astellas Pharma US, Inc., the manufacturer of Padcev. [read post]
28 Apr 2020, 11:46 pm
by Olivia Henry and Nicholas Michelmore On 20 April 2020, Arnold LJ (sitting as a High Court Judge) gave judgment in the case between FibroGen Inc and Astellas Pharma Inc (together the “Claimants”), and Akebia Therapeutics Inc and Otsuka Pharmaceutical Company Limited (together the “Defendants”) which concerned six patents owned by FibroGen and exclusively licensed to Astellas (the “Patents”). [read post]
27 Jan 2020, 5:26 pm
, Amgen Inc., Astellas Pharma US Inc. [read post]
10 Jan 2020, 7:09 am
, Amgen Inc., Astellas Pharma US Inc. [read post]
11 Oct 2018, 1:24 pm
., in support of DISC2-10973, PI Jonathan Lin of UC San Diego, dealing with photoreceptor diseases (score 88 out of 100)Laura Brady, research manager, Fighting Blindness of Dublin, Ireland, also in support of DISC2-10973Avril Daly, CEO, Retina International, also in support of DISC2-10973.Philip Beachy, Ernest and Amelia Gallo professor, Stanford, in support of his application, DISC2-11105, dealing with bladder cancer (score 90 out of 100)Don Reed, vice president of public policy,… [read post]
9 Aug 2018, 12:08 pm
In 2016 it was purchased by Astellas Pharma of Japan for $379 million. [read post]
31 May 2018, 4:26 pm
Background Astellas Pharma U.S. is a pharmaceutical company and the U.S-based subsidiary of Astellas Pharma, Inc. [read post]
12 Nov 2017, 6:10 pm
Astellas Pharma Inc. [read post]
12 Jul 2016, 7:22 am
Both defendants in the case have since been purchased by other firms – OSI by Japanese company Astellas Pharma and Genetech by Swiss firm Hoffman-La Roche AG. [read post]
30 Mar 2016, 8:27 am
U.S. lawmakers want prostate cancer drugs lowered, who called on the National Institutes of Health and Human Services to reduce the costs of Xtandi, Medivation Inc’s and Astellas Pharma Inc’s prostate cancer drug. [read post]
7 Feb 2016, 9:59 pm
Astellas Pharma Inc. et al. v. [read post]
19 Aug 2015, 10:43 am
Presented by Astellas Pharma, Inc., the event took place during the WGC-Bridgestone Invitational. [read post]
3 Sep 2014, 4:01 pm
This is the question which the IPKat posed last Friday, on learning that Case C-661/13 Astellas Pharma Inc. v Polpharma SA Pharmaceutical Works, a reference to the Court of Justice of the European Union (CJEU) of some questions relating to the so-called Bolar exemption, which spares some sorts of use of someone else's patent for experimental purposes from being a patent infringement. [read post]
29 Aug 2014, 7:30 am
Readers may still be looking forward to a ruling from the Court of Justice of the European Union (CJEU) in Case C-661/13 Astellas Pharma Inc. v Polpharma SA Pharmaceutical Works, which was excitedly publicised by this Kat here and here on account of its potential for clarifying the scope of Bolar exemptions from patent infringement in favour of experimental use. [read post]
